ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO158

Global but Not Tubule Cell-Specific Knockout of STING Attenuates Kidney Injury in Mice with Unilateral Ureteral Obstruction

Session Information

  • AKI: Mechanisms
    October 25, 2024 | Location: Exhibit Hall, Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Acute Kidney Injury

  • 103 AKI: Mechanisms

Authors

  • Yeung, Emily S.H., Keenan Research Centre for Biomedical Science, St. Michael’s Hospital, Toronto, Ontario, Canada
  • Syeda, Madiha Zahra, Keenan Research Centre for Biomedical Science, St. Michael’s Hospital, Toronto, Ontario, Canada
  • Tran, Duc Tin, Keenan Research Centre for Biomedical Science, St. Michael’s Hospital, Toronto, Ontario, Canada
  • Advani, Suzanne L., Keenan Research Centre for Biomedical Science, St. Michael’s Hospital, Toronto, Ontario, Canada
  • Liu, Youan, Keenan Research Centre for Biomedical Science, St. Michael’s Hospital, Toronto, Ontario, Canada
  • Batchu, Sri nagarjun, Keenan Research Centre for Biomedical Science, St. Michael’s Hospital, Toronto, Ontario, Canada
  • Advani, Andrew, Keenan Research Centre for Biomedical Science, St. Michael’s Hospital, Toronto, Ontario, Canada
Background

Recent studies have identified a key role for the inflammatory mediator STING in kidney injury. Because it is activated by the cellular response to displaced DNA, it has been proposed that STING mediates kidney injury when mitochondrial DNA leaks into the cytosol of damaged tubule epithelial cells. However, STING is not specific to tubule cells, also having an important regulatory function in other cell-types, amongst them immune cells. Here, we compared the effects of deletion of STING from tubule cells with the effects of global STING deletion in mice with kidney injury caused by unilateral ureteral obstruction (UUO).

Methods

Experiments were performed in wildtype mice, Stingfl/fl mice, Pax8Cre+Stingfl/fl mice (tubule cell-specific STING knockout mice; STINGTubKO) and global STING knockout mice (STINGKO) 14 days after sham surgery or UUO.

Results

mRNA and protein levels of STING were both increased >5-fold in mice after UUO. In situ hybridization and immunostaining confirmed presence of STING in damaged tubule cells, occasional glomerular cells and notably in infiltrating interstitial cells in UUO kidneys. Knockout of STING was confirmed in STINGKO mice by immunoblotting; and in STINGTubKO mice by immunohistochemistry 24h after ischemia reperfusion injury. Kidney injury was then determined by measuring mRNA levels of Havcr1, the gene encoding KIM-1, in control (Stingfl/fl) mice, STINGTubKO mice and STINGKO mice 14 days after UUO or sham surgery. Havcr1 mRNA levels were increased >120-fold in Stingfl/fl mice after UUO and they were unaffected by tubule-cell specific STING knockout. In contrast, Havcr1 mRNA levels after UUO, while increased >60-fold in global STING knockout mice, and were significantly lower than in Stingfl/fl and STINGTubKO mice after UUO (P<0.01).

Conclusion

Kidney injury in UUO mice, as assessed by Havcr1 mRNA levels, is attenuated by global STING deficiency rather than tubule cell-specific STING deficiency. These findings indicate that the actions of STING in kidney disease extend beyond mediating the response to mitochondrial damage in tubule cells. The effects of STING may be primarily due to its actions in other cell-types, especially in infiltrating immune cells.

Funding

  • Government Support – Non-U.S.